Q-linea AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QLINEA.ST research report →
Companywww.qlinea.com
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures.
- CEO
- Anders Ljunggren
- IPO
- 2018
- Employees
- 97
- HQ
- Uppsala, SE
Price Chart
Valuation
- Market Cap
- $113.22M
- P/E
- -1.89
- P/S
- 11.99
- P/B
- 1.06
- EV/EBITDA
- 0.71
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -1905.52%
- Op Margin
- -1799.17%
- Net Margin
- -1809.29%
- ROE
- -79.51%
- ROIC
- -55.05%
Growth & Income
- Revenue
- $11.10M · 369.86%
- Net Income
- $-182,485,000 · 15.86%
- EPS
- $-27.40 · -10438.46%
- Op Income
- $-180,019,000
- FCF YoY
- 9.50%
Performance & Tape
- 52W High
- $79.00
- 52W Low
- $14.55
- 50D MA
- $20.29
- 200D MA
- $27.18
- Beta
- 1.59
- Avg Volume
- 10.64K
Get TickerSpark's AI analysis on QLINEA.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our QLINEA.ST Coverage
We haven't published any research on QLINEA.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QLINEA.ST Report →